The 23andMe headquarters in Sunnyvale, California in 2024. Correspondent The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night ...

Health care will be more personalized because that's what consumers want, said Anne Wojcicki, the co-founder and CEO of 23andMe genomics profile company, in a conversation with Bloomberg's Emily Chang ...

This morning, consumer genomic giant 23andMe revealed that it is teaming up with Lark Health, an AI platform that helps users manage chronic conditions, on a new initiative that will integrate a ...

PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...

AI for drug development is very fashionable in biotech, and for good reason. 23andMe's consumer business could one day provide a bedrock of stability. Recursion Pharmaceutical's research services ...

Andy Page, former president of digital health startups 23andMe and Livongo, joined Caption Health as CEO earlier this year, the San Francisco-based artificial intelligence company announced Oct. 1.

The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely ...

Recursion Pharmaceuticals (NASDAQ: RXRX) and 23andMe (NASDAQ: ME) are both popular biotech stocks that are wooing investors with their claims about using artificial intelligence (AI) to supercharge ...